Tag:#Medicinal Cannabis

Oxford Cannabinoid Technologies Signs New Agreement With Stemtech

OCT believes Stemtech’s technology provides an in vitro translational model that will better predict results in humans.

Irish Clinical Establishment Continues To Shun Cannabis Leaving Medical Access Programme Doomed to Failure

Drug policy specialist Natalie O'Regan on Ireland's faltering Medical Cannabis Access Programme THE Medical Cannabis Access Programme (MCAP) was launched in 2017, four years later...

Kanabo Aiming To Become Europe’s First Cannabis ‘Unicorn’

UK Market-listed cannabis business Kanabo is now generating its first revenues following the successful launch of its flagship VapePod product.  The medical cannabis vapes were...

Is CBD A Boom-Or-Bust Fad – Or A Major FMCG Opportunity?

SUGGESTIONS that CBD is a fad - a boom-to-bust market - with the latter imminent, raised a few eyebrows at Cannabis Europa.  In an occasionally...

Heath Minister Says Lack Of UK Medical Cannabis Scripts Is a Clinical Issue – Not A Political One

DESPITE coming under increasing pressure to unblock the medical cannabis prescribing impasse the UK Government this week continued to distance itself from the issue. Three...

UK Cannabis Company’s C-Suite Left ‘Shaking Their Heads’ In Disbelief At Company’s Poor Stock Performance 

FOLLOWING its listing on the London Stock Exchange in May this year Oxford Cannabinoid Technologies (OCT) has seen more than £20m wiped off its...

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council have been identified following a special general meeting attended by around 50 members. The meeting in...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science, Dr Anne Katrin Schlag, heads up the newly formed Cannabis Industry Council’s (CIC) Research group. With...

Latest news

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover...
- Advertisement -spot_imgspot_img

Columbia Care Platinum Joins Forces With Poppy Jamie

Leading organic, vegan and regeneratively-farmed, plant-based CBD brand, Columbia Care Platinum(www.shop.col-care.uk), announces it has teamed up with Poppy Jamie, mental wellbeing...

InterCure Announces European Expansion with International Cannabis Brand Cookies

InterCure Ltd. today announced its international expansion into Europe through a partnership with iconic cannabis brand Cookies. The parties entered...

Must read

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior...